Genexine - M&A Summary and Business Overview

Life ScienceCompany

Genexine M&A Summary

Genexine has acquired 1 company, including 1 in the last 5 years.

Genexine’s largest acquisition to date was in 2019, when it acquired Argos Therapeutics for $11M. Genexine has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Genexine Business Overview

Where is Genexine headquartered?

Genexine is headquartered in Seongnam, South Korea.

What is Genexine’s revenue?

Genexine disclosed revenue of 6,251M KRW for 2012 and 2,661M KRW for 2011.

How many employees does Genexine have?

Genexine has 123 employees.

What sector is Genexine in?

Genexine is a life science company.

When was Genexine founded?

Genexine was founded in 1999.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Genexine

Genexine, Inc.

Korea Bio Park Building B 700 Daewangpangyo-ro Bundang-gu,
Seongnam, 13488
South Korea,
+82 31 628 3200
www.genexine.com

Genexine is a clinical-stage biotechnology company focused on the development and commercialization of innovative immunotherapeutics and next-generation novel long-acting biologics. Genexine is based in Gyeonggi-do, South Korea. Genexine was founded in 1999 and is based in Seongnam, South Korea.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
vol $11M $11M
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Argos Therapeutics, Inc. 2019-02-13 11M USD Add-on Acquisition
Durham, North Carolina · www.argostherapeutics.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 11M (100%) - -
Total 1 $11M - -

By Geo

State/Country Buy Value Sell Value
United States 1 11M - -
  North Carolina 1 11M - -
Total 1 $11M - -

Deal Values

buy # Total
< $100M 1 $11M
TOTAL $11M
Largest Argos Therapeutics, Inc.
$11M (2019-02-13)

 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Genexine

Life Science Companies , South Korea Companies